Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Baxter
Fuji
US Army
AstraZeneca
McKinsey
QuintilesIMS
US Department of Justice
McKesson

Generated: November 19, 2018

DrugPatentWatch Database Preview

Ferring Company Profile

« Back to Dashboard

What is the competitive landscape for FERRING, and when can generic versions of FERRING drugs launch?

FERRING has twenty-six approved drugs.

There are twenty-four US patents protecting FERRING drugs.

Summary for Ferring
US Patents:24
Tradenames:26
Ingredients:14
NDAs:26
Patent Litigation for Ferring: See patent lawsuits for Ferring

Drugs and US Patents for Ferring

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes 8,022,106 ➤ Try a Free Trial ➤ Try a Free Trial
Ferring BRAVELLE urofollitropin INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 021289-001 May 6, 2002 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-002 Jun 21, 2018 RX Yes Yes 7,947,654 ➤ Try a Free Trial Y ➤ Try a Free Trial
Ferring Pharms Inc NOCDURNA desmopressin acetate TABLET;SUBLINGUAL 022517-001 Jun 21, 2018 RX Yes No 7,947,654 ➤ Try a Free Trial Y ➤ Try a Free Trial
Ferring Pharms Inc LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes 8,273,795 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Ferring

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc DDAVP desmopressin acetate SPRAY, METERED;NASAL 017922-002 Feb 6, 1989 5,763,407 ➤ Try a Free Trial
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982 5,763,407 ➤ Try a Free Trial
Ferring Pharms Inc DDAVP desmopressin acetate SOLUTION;NASAL 017922-001 Approved Prior to Jan 1, 1982 5,674,850 ➤ Try a Free Trial
Ferring ACTHREL corticorelin ovine triflutate INJECTABLE;INJECTION 020162-001 May 23, 1996 4,415,558 ➤ Try a Free Trial
Ferring Pharms Inc DDAVP desmopressin acetate TABLET;ORAL 019955-001 Sep 6, 1995 5,763,407 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for FERRING drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 650 mg ➤ Subscribe 2011-05-24
➤ Subscribe Oral Solution 10 mg, 3.5 g, and 12 g ➤ Subscribe 2014-05-21

Supplementary Protection Certificates for Ferring Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2009000033 Germany ➤ Try a Free Trial PRODUCT NAME: DEGARELIX, GGF. IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES DAVON, WIE DEM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001-002 20090217
2009005 Lithuania ➤ Try a Free Trial PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217
2009 00022 Denmark ➤ Try a Free Trial
0395 Netherlands ➤ Try a Free Trial 300395, 20180413, EXPIRES: 20230412
1003774/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: DEGARELIX; REGISTRATION NUMBER/DATE: SWISSMEDIC 59455 12.02.2010
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Accenture
Merck
Deloitte
Boehringer Ingelheim
US Army
Dow
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.